{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:12:49Z","timestamp":1791673969935,"version":"4.3.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS110749"],"award-info":[{"award-number":["R01NS110749"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16SDG2719001"],"award-info":[{"award-number":["16SDG2719001"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20PRE35080166"],"award-info":[{"award-number":["20PRE35080166"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypothalamic dysfunction occurs early in the clinical course of Alzheimer\u2019s disease (AD), likely contributing to disturbances in feeding behavior and metabolic function that are often observed years prior to the onset of cognitive symptoms. Late-life weight loss and low BMI are associated with increased risk of dementia and faster progression of disease. However, high-fat diet and metabolic disease (e.g., obesity, type 2 diabetes), particularly in mid-life, are associated with increased risk of AD, as well as exacerbated AD pathology and behavioral deficits in animal models. In the current study, we explored possible relationships between hypothalamic function, diet\/metabolic status, and AD. Considering the sex bias in AD, with women representing two-thirds of AD patients, we sought to determine whether these relationships vary by sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>WT and 3xTg-AD male and female mice were fed a control (10% fat) or high-fat (HF 60% fat) diet from ~ 3\u20137\u2009months of age, then tested for metabolic and hypothalamic disturbances.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>On control diet, male 3xTg-AD mice displayed decreased body weight, reduced fat mass, hypoleptinemia, and mild systemic inflammation, as well as increased expression of gliosis- and inflammation-related genes in the hypothalamus (Iba1, GFAP, TNF-\u03b1, IL-1\u03b2). In contrast, female 3xTg-AD mice on control diet displayed metabolic disturbances opposite that of 3xTg-AD males (increased body and fat mass, impaired glucose tolerance). HF diet resulted in expected metabolic alterations across groups (increased body and fat mass; glucose intolerance; increased plasma insulin and leptin, decreased ghrelin; nonalcoholic fatty liver disease-related pathology). HF diet resulted in the greatest weight gain, adiposity, and glucose intolerance in 3xTg-AD females, which were associated with markedly increased hypothalamic expression of GFAP and IL-1\u03b2, as well as GFAP labeling in several hypothalamic nuclei that regulate energy balance. In contrast, HF diet increased diabetes markers and systemic inflammation preferentially in AD males but did not exacerbate hypothalamic inflammation in this group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings provide further evidence for the roles of hypothalamic and metabolic dysfunction in AD, which in the 3xTg-AD mouse model appears to be dependent on both sex and diet.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-020-01956-5","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T12:38:29Z","timestamp":1601383109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Lisa S.","family":"Robison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia J.","family":"Gannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail E.","family":"Salinero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charly","family":"Abi-Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Poitelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Belin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5395-7362","authenticated-orcid":false,"given":"Kristen L.","family":"Zuloaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"issue":"1","key":"1956_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63\u201375.e2.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1956_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cmet.2015.08.016","volume":"22","author":"M Ishii","year":"2015","unstructured":"Ishii M, Iadecola C. Metabolic and non-cognitive manifestations of Alzheimer\u2019s disease: the hypothalamus as both culprit and target of pathology. Cell Metab. 2015;22(5):761\u201376.","journal-title":"Cell Metab"},{"issue":"10","key":"1956_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1532-5415.1998.tb04537.x","volume":"46","author":"H White","year":"1998","unstructured":"White H, Pieper C, Schmader K. The association of weight change in Alzheimer\u2019s disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998;46(10):1223\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1956_CR4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","volume":"65","author":"AS Buchman","year":"2005","unstructured":"Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005;65(6):892\u20137.","journal-title":"Neurology."},{"issue":"3","key":"1956_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151710","volume":"11","author":"I Cova","year":"2016","unstructured":"Cova I, Clerici F, Rossi A, Cucumo V, Ghiretti R, Maggiore L, et al. Weight loss predicts progression of mild cognitive impairment to Alzheimer\u2019s disease. PLoS One. 2016;11(3):e0151710.","journal-title":"PLoS One"},{"issue":"2","key":"1956_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/ajcn\/82.2.435","volume":"82","author":"O Gu\u00e9rin","year":"2005","unstructured":"Gu\u00e9rin O, Andrieu S, Schneider SM, Milano M, Boulahssass R, Brocker P, et al. Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients. Am J Clin Nutr. 2005;82(2):435\u201341.","journal-title":"Am J Clin Nutr"},{"issue":"78","key":"1956_CR7","doi-asserted-by":"publisher","first-page":"34691","DOI":"10.18632\/oncotarget.26162","volume":"9","author":"J Pegueroles","year":"2018","unstructured":"Pegueroles J, Jim\u00e9nez A, Vilaplana E, Montal V, Carmona-Iragui M, Pan\u00e9 A, et al. Obesity and Alzheimer\u2019s disease, does the obesity paradox really exist? A magnetic resonance imaging study. Oncotarget. 2018;9(78):34691\u20138.","journal-title":"Oncotarget."},{"key":"1956_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2020.03.002","volume":"93","author":"JS Rabin","year":"2020","unstructured":"Rabin JS, Shirzadi Z, Swardfager W, MacIntosh BJ, Schultz A, Yang H-S, et al. Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults. Neurobiol Aging. 2020;93:124\u201330.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1956_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3233\/JAD-150987","volume":"53","author":"DC Hsu","year":"2016","unstructured":"Hsu DC, Mormino EC, Schultz AP, Amariglio RE, Donovan NJ, Rentz DM, et al. Lower late-life body-mass index is associated with higher cortical amyloid burden in clinically normal elderly. J Alzheimers Dis. 2016;53(3):1097\u2013105.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"1956_CR10","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.neurobiolaging.2011.05.005","volume":"33","author":"M Ewers","year":"2012","unstructured":"Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, et al. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33(8):1599\u2013608.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1956_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1567205010666131120110930","volume":"11","author":"Y Gu","year":"2014","unstructured":"Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, et al. Change in body mass index before and after Alzheimer\u2019s disease onset. Curr Alzheimer Res. 2014;11(4):349\u201356.","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"1956_CR12","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/archneur.63.9.1312","volume":"63","author":"DK Johnson","year":"2006","unstructured":"Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol. 2006;63(9):1312\u20137.","journal-title":"Arch Neurol"},{"issue":"1","key":"1956_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41598-017-01327-w","volume":"7","author":"S M\u00fcller","year":"2017","unstructured":"M\u00fcller S, Preische O, Sohrabi HR, Gr\u00e4ber S, Jucker M, Dietzsch J, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer\u2019s disease. Sci Rep. 2017;7(1):1225.","journal-title":"Sci Rep"},{"issue":"2","key":"1956_CR14","doi-asserted-by":"publisher","first-page":"T25","DOI":"10.1530\/JOE-13-0398","volume":"220","author":"M Schneeberger","year":"2014","unstructured":"Schneeberger M, Gomis R, Claret M. Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance. J Endocrinol. 2014;220(2):T25.","journal-title":"J Endocrinol"},{"issue":"6","key":"1956_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1242\/dmm.026609","volume":"10","author":"K Timper","year":"2017","unstructured":"Timper K, Br\u00fcning JC. Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity. Dis Model Mech. 2017;10(6):679\u201389.","journal-title":"Dis Model Mech"},{"issue":"1","key":"1956_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-2010-1364","volume":"20","author":"N Loskutova","year":"2010","unstructured":"Loskutova N, Honea RA, Brooks WM, Burns JM. Reduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer\u2019s disease. J Alzheimers Dis. 2010;20(1):313\u201322.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1956_CR17","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1212\/WNL.57.9.1669","volume":"57","author":"DJ Callen","year":"2001","unstructured":"Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology. 2001;57(9):1669\u201374.","journal-title":"Neurology."},{"issue":"4","key":"1956_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jalz.2008.04.005","volume":"4","author":"AM Hall","year":"2008","unstructured":"Hall AM, Moore RY, Lopez OL, Kuller L, Becker JT. Basal forebrain atrophy is a presymptomatic marker for Alzheimer\u2019s disease. Alzheimers Dement. 2008;4(4):271\u20139.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"1956_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00259-002-0816-3","volume":"29","author":"DJ Callen","year":"2002","unstructured":"Callen DJ, Black SE, Caldwell CB. Limbic system perfusion in Alzheimer\u2019s disease measured by MRI-coregistered HMPAO SPET. Eur J Nucl Med Mol Imaging. 2002;29(7):899\u2013906.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"1956_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.neurobiolaging.2003.08.011","volume":"25","author":"DJ Callen","year":"2004","unstructured":"Callen DJ, Black SE, Caldwell CB, Grady CL. The influence of sex on limbic volume and perfusion in AD. Neurobiol Aging. 2004;25(6):761\u201370.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1956_CR21","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.2967\/jnumed.112.116558","volume":"54","author":"DJ Cross","year":"2013","unstructured":"Cross DJ, Anzai Y, Petrie EC, Martin N, Richards TL, Maravilla KR, et al. Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment. J Nucl Med. 2013;54(8):1278\u201384.","journal-title":"J Nucl Med"},{"issue":"1","key":"1956_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbadis.2017.10.028","volume":"1864","author":"H Zheng","year":"2018","unstructured":"Zheng H, Zhou Q, Du Y, Li C, Xu P, Lin L, et al. The hypothalamus as the primary brain region of metabolic abnormalities in APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2018;1864(1):263\u201373.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"1","key":"1956_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/nbdi.2001.0460","volume":"9","author":"K Niwa","year":"2002","unstructured":"Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis. 2002;9(1):61\u20138.","journal-title":"Neurobiol Dis"},{"issue":"27","key":"1956_CR24","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.1523\/JNEUROSCI.0872-14.2014","volume":"34","author":"M Ishii","year":"2014","unstructured":"Ishii M, Wang G, Racchumi G, Dyke JP, Iadecola C. Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons. J Neurosci. 2014;34(27):9096\u2013106.","journal-title":"J Neurosci"},{"issue":"2","key":"1956_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/157339508784325046","volume":"4","author":"N Iikuni","year":"2008","unstructured":"Iikuni N, Lam QLK, Lu L, Matarese G, La Cava A. Leptin and inflammation. Curr Immunol Rev. 2008;4(2):70\u20139.","journal-title":"Curr Immunol Rev"},{"issue":"15","key":"1956_CR26","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1096\/fj.04-2572com","volume":"18","author":"DC Fewlass","year":"2004","unstructured":"Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N. Obesity-related leptin regulates Alzheimer\u2019s A\u03b2. FASEB J. 2004;18(15):1870\u20138.","journal-title":"FASEB J"},{"issue":"2","key":"1956_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10571-015-0282-7","volume":"36","author":"MJ McGuire","year":"2016","unstructured":"McGuire MJ, Ishii M. Leptin dysfunction and Alzheimer\u2019s disease: evidence from cellular, animal, and human studies. Cell Mol Neurobiol. 2016;36(2):203\u201317.","journal-title":"Cell Mol Neurobiol"},{"key":"1956_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fncel.2014.00022","volume":"8","author":"N El Khoury","year":"2014","unstructured":"El Khoury N, Gratuze M, Papon M-A, Bretteville A, Planel E. Insulin dysfunction and tau pathology. Front Cell Neurosci. 2014;8:22.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1956_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/11597760-000000000-00000","volume":"72","author":"SM de la Monte","year":"2012","unstructured":"de la Monte SM. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer\u2019s disease. Drugs. 2012;72(1):49\u201366.","journal-title":"Drugs."},{"issue":"1","key":"1956_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12974-015-0282-z","volume":"12","author":"L Adzovic","year":"2015","unstructured":"Adzovic L, Lynn AE, D\u2019Angelo HM, Crockett AM, Kaercher RM, Royer SE, et al. Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains. J Neuroinflammation. 2015;12(1):63.","journal-title":"J Neuroinflammation"},{"key":"1956_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuropharm.2017.09.038","volume":"136","author":"G McGregor","year":"2018","unstructured":"McGregor G, Harvey J. Food for thought: leptin regulation of hippocampal function and its role in Alzheimer\u2019s disease. Neuropharmacology. 2018;136:298\u2013306.","journal-title":"Neuropharmacology."},{"issue":"4","key":"1956_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nlm.2010.02.002","volume":"93","author":"EC McNay","year":"2010","unstructured":"McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem. 2010;93(4):546\u201353.","journal-title":"Neurobiol Learn Mem"},{"issue":"11","key":"1956_CR33","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.2337\/dbi15-0011","volume":"64","author":"FG De Felice","year":"2015","unstructured":"De Felice FG, Benedict C. A key role of insulin receptors in memory. Diabetes. 2015;64(11):3653\u20135.","journal-title":"Diabetes."},{"issue":"3","key":"1956_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2337\/db14-1000","volume":"64","author":"H Zhang","year":"2015","unstructured":"Zhang H, Hao Y, Manor B, Novak P, Milberg W, Zhang J, et al. Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes. 2015;64(3):1025\u201334.","journal-title":"Diabetes."},{"key":"1956_CR35","doi-asserted-by":"crossref","unstructured":"Xue M, Xu W, Ou Y-N, Cao X-P, Tan M-S, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;100944.","DOI":"10.1016\/j.arr.2019.100944"},{"issue":"2","key":"1956_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/156720507780362047","volume":"4","author":"RA Whitmer","year":"2007","unstructured":"Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007;4(2):103\u20139.","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"1956_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","volume":"53","author":"J Janson","year":"2004","unstructured":"Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004;53(2):474\u201381.","journal-title":"Diabetes."},{"issue":"2","key":"1956_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 2010;31(2):224\u201343.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1956_CR39","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122(4):1316\u201338.","journal-title":"J Clin Invest"},{"issue":"1","key":"1956_CR40","doi-asserted-by":"publisher","first-page":"25589","DOI":"10.1038\/srep25589","volume":"6","author":"K Mittal","year":"2016","unstructured":"Mittal K, Mani RJ, Katare DP. Type 3 diabetes: cross talk between differentially regulated proteins of type 2 diabetes mellitus and Alzheimer\u2019s disease. Sci Rep. 2016;6(1):25589.","journal-title":"Sci Rep"},{"issue":"9","key":"1956_CR41","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.neurobiolaging.2008.08.022","volume":"31","author":"C Julien","year":"2010","unstructured":"Julien C, Tremblay C, Phivilay A, Berthiaume L, \u00c9mond V, Julien P, et al. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging. 2010;31(9):1516\u201331.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"1956_CR42","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1096\/fj.03-0978fje","volume":"18","author":"L Ho","year":"2004","unstructured":"Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, et al. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease. FASEB J. 2004;18(7):902\u20134.","journal-title":"FASEB J"},{"issue":"10","key":"1956_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078554","volume":"8","author":"AM Barron","year":"2013","unstructured":"Barron AM, Rosario ER, Elteriefi R, Pike CJ. Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer\u2019s disease. PLoS One. 2013;8(10):e78554.","journal-title":"PLoS One"},{"issue":"15","key":"1956_CR44","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1073\/pnas.1000645107","volume":"107","author":"S Takeda","year":"2010","unstructured":"Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A\u03b2 deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci. 2010;107(15):7036\u201341.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1956_CR45","doi-asserted-by":"publisher","first-page":"9884","DOI":"10.1038\/s41598-020-65908-y","volume":"10","author":"O Bracko","year":"2020","unstructured":"Bracko O, Vinarcsik LK, Cruz Hern\u00e1ndez JC, Ruiz-Uribe NE, Haft-Javaherian M, Falkenhain K, et al. High fat diet worsens Alzheimer\u2019s disease-related behavioral abnormalities and neuropathology in APP\/PS1 mice, but not by synergistically decreasing cerebral blood flow. Sci Rep. 2020;10(1):9884.","journal-title":"Sci Rep"},{"issue":"4","key":"1956_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7762\/cnr.2018.7.4.229","volume":"7","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Seo HI, Cha HY, Yang YJ, Kwon SH, Yang SJ. Diabetes and Alzheimer\u2019s disease: mechanisms and nutritional aspects. Clin Nutr Res. 2018;7(4):229\u201340.","journal-title":"Clin Nutr Res"},{"issue":"5","key":"1956_CR47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","volume":"1792","author":"W-Q Zhao","year":"2009","unstructured":"Zhao W-Q, Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2009;1792(5):482\u201396.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"5","key":"1956_CR48","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1586\/ern.09.18","volume":"9","author":"PA Maher","year":"2009","unstructured":"Maher PA, Schubert DR. Metabolic links between diabetes and Alzheimer\u2019s disease. Expert Rev Neurother. 2009;9(5):617\u201330.","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"1956_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15252\/emmm.201404183","volume":"7","author":"JR Clarke","year":"2015","unstructured":"Clarke JR, Lyra ESNM, Figueiredo CP, Frozza RL, Ledo JH, Beckman D, et al. Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Mol Medi. 2015;7(2):190\u2013210.","journal-title":"EMBO Mol Medi"},{"issue":"9","key":"1956_CR50","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","volume":"90","author":"EK Spengler","year":"2015","unstructured":"Spengler EK, Loomba R. Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc. 2015;90(9):1233\u201346.","journal-title":"Mayo Clin Proc"},{"key":"1956_CR51","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, et al. Nonalcoholic fatty liver disease. Nature Rev Dis Primers. 2015;1:15080.","journal-title":"Nature Rev Dis Primers"},{"issue":"47","key":"1956_CR52","doi-asserted-by":"publisher","first-page":"e8753","DOI":"10.1097\/MD.0000000000008753","volume":"96","author":"HM Kim","year":"2017","unstructured":"Kim HM, Lee Y-H, Han K, Lee B-W, Kang ES, Kim J, et al. Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia. Medicine. 2017;96(47):e8753.","journal-title":"Medicine"},{"key":"1956_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnagi.2019.00174","volume":"11","author":"LD Estrada","year":"2019","unstructured":"Estrada LD, Ahumada P, Cabrera D, Arab JP. Liver dysfunction as a novel player in Alzheimer\u2019s progression: looking outside the brain. Front Aging Neurosci. 2019;11:174.","journal-title":"Front Aging Neurosci"},{"issue":"1 Supplement","key":"1956_CR54","doi-asserted-by":"crossref","first-page":"188.4","DOI":"10.4049\/jimmunol.196.Supp.188.4","volume":"196","author":"MS Bynoe","year":"2016","unstructured":"Bynoe MS. NAFLD induces neuroinflammation and accelerates Alzheimer\u2019s disease. J Immunol. 2016;196(1 Supplement):188.4.","journal-title":"J Immunol"},{"key":"1956_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0467-5","volume":"13","author":"D-G Kim","year":"2016","unstructured":"Kim D-G, Krenz A, Toussaint LE, Maurer KJ, Robinson S-A, Yan A, et al. Non-alcoholic fatty liver disease induces signs of Alzheimer\u2019s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. J Neuroinflammation. 2016;13:1.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1956_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yfrne.2014.01.002","volume":"35","author":"R Li","year":"2014","unstructured":"Li R, Singh M. Sex differences in cognitive impairment and Alzheimer\u2019s disease. Front Neuroendocrinol. 2014;35(3):385\u2013403.","journal-title":"Front Neuroendocrinol"},{"issue":"9","key":"1956_CR57","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ijo.2008.102","volume":"32","author":"T Kelly","year":"2008","unstructured":"Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431\u20137.","journal-title":"Int J Obes"},{"issue":"3","key":"1956_CR58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39(3):409\u201321.","journal-title":"Neuron."},{"issue":"5","key":"1956_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice. Neuron. 2005;45(5):675\u201388.","journal-title":"Neuron."},{"issue":"5","key":"1956_CR60","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41366-018-0023-3","volume":"42","author":"AE Salinero","year":"2018","unstructured":"Salinero AE, Anderson BM, Zuloaga KL. Sex differences in the metabolic effects of diet-induced obesity vary by age of onset. Int J Obes. 2018;42(5):1088\u201391.","journal-title":"Int J Obes"},{"issue":"6","key":"1956_CR61","doi-asserted-by":"publisher","first-page":"R903","DOI":"10.1152\/ajpregu.00046.2019","volume":"317","author":"MM Hyer","year":"2019","unstructured":"Hyer MM, Dyer SK, Kloster A, Adrees A, Taetzsch T, Feaster J, et al. Sex modifies the consequences of extended fructose consumption on liver health, motor function, and physiological damage in rats. Am J Physiol Regul Integr Comp Physiol. 2019;317(6):R903\u2013r11.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1956_CR62","first-page":"89","volume":"8","author":"K Vl\u010dek","year":"2014","unstructured":"Vl\u010dek K, Lacz\u00f3 J. Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer\u2019s disease. Front Behav Neurosci. 2014;8:89.","journal-title":"Front Behav Neurosci"},{"key":"1956_CR63","doi-asserted-by":"publisher","first-page":"h369","DOI":"10.1136\/bmj.h369","volume":"350","author":"HC Kales","year":"2015","unstructured":"Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. Bmj. 2015;350:h369.","journal-title":"Bmj."},{"issue":"1","key":"1956_CR64","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1210\/en.2005-0998","volume":"147","author":"JM Daniel","year":"2006","unstructured":"Daniel JM, Hulst JL, Berbling JL. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology. 2006;147(1):607\u201314.","journal-title":"Endocrinology."},{"issue":"5","key":"1956_CR65","doi-asserted-by":"publisher","first-page":"e0197441","DOI":"10.1371\/journal.pone.0197441","volume":"13","author":"YK Matsumoto","year":"2018","unstructured":"Matsumoto YK, Kasai M, Tomihara K. The enhancement effect of estradiol on contextual fear conditioning in female mice. PLoS One. 2018;13(5):e0197441\u2013e.","journal-title":"PLoS One"},{"issue":"1","key":"1956_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0031-9384(92)90198-B","volume":"51","author":"MD Even","year":"1992","unstructured":"Even MD, vom Saal FS. Seminal vesicle and preputial gland response to steroids in adult male mice is influenced by prior intrauterine position. Physiol Behavior. 1992;51(1):11\u20136.","journal-title":"Physiol Behavior"},{"issue":"12","key":"1956_CR67","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2337\/dbi18-0024","volume":"67","author":"BN Finck","year":"2018","unstructured":"Finck BN. Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis. Diabetes. 2018;67(12):2485\u201393.","journal-title":"Diabetes."},{"issue":"1","key":"1956_CR68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1467-789X.2006.00270.x","volume":"8","author":"M Klok","year":"2007","unstructured":"Klok M, Jakobsdottir S, Drent M. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obesity Rev. 2007;8(1):21\u201334.","journal-title":"Obesity Rev"},{"key":"1956_CR69","first-page":"57","volume":"11","author":"A Ojha","year":"2019","unstructured":"Ojha A, Ojha U, Mohammed R, Chandrashekar A, Ojha H. Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus. Clin Pharmacol. 2019;11:57\u201365.","journal-title":"Clin Pharmacol"},{"issue":"1-2","key":"1956_CR70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","volume":"1","author":"Y Seino","year":"2010","unstructured":"Seino Y, Fukushima M, Yabe D. GIP and GLP-1, the two incretin hormones: similarities and differences. J Diabetes Investig. 2010;1(1-2):8\u201323.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"1956_CR71","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28(5):e72\u201391.","journal-title":"Cardiovasc Ther"},{"issue":"7","key":"1956_CR72","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ijo.2009.96","volume":"33","author":"NM Semjonous","year":"2009","unstructured":"Semjonous NM, Smith KL, Parkinson JR, Gunner DJ, Liu YL, Murphy KG, et al. Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int J Obesity (2005). 2009;33(7):775\u201385.","journal-title":"Int J Obesity (2005)"},{"issue":"12","key":"1956_CR73","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/embor.2012.174","volume":"13","author":"L Varela","year":"2012","unstructured":"Varela L, Horvath TL. Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep. 2012;13(12):1079\u201386.","journal-title":"EMBO Rep"},{"key":"1956_CR74","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fendo.2019.00524","volume":"10","author":"LI Arhire","year":"2019","unstructured":"Arhire LI, Mihalache L, Covasa M. Irisin: a hope in understanding and managing obesity and metabolic syndrome. Front Endocrinol. 2019;10:524.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1956_CR75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI88878","volume":"127","author":"A Jais","year":"2017","unstructured":"Jais A, Br\u00fcning JC. Hypothalamic inflammation in obesity and metabolic disease. J Clin Invest. 2017;127(1):24\u201332.","journal-title":"J Clin Invest"},{"key":"1956_CR76","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fendo.2017.00197","volume":"8","author":"O Le Thuc","year":"2017","unstructured":"Le Thuc O, Stobbe K, Cansell C, Nahon J-L, Blondeau N, Rov\u00e8re C. Hypothalamic inflammation and energy balance disruptions: spotlight on chemokines. Front Endocrinol. 2017;8:197.","journal-title":"Front Endocrinol"},{"issue":"Pt 17","key":"1956_CR77","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1242\/jcs.113.17.3073","volume":"113","author":"K Ohsawa","year":"2000","unstructured":"Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages\/microglia. J Cell Sci. 2000;113(Pt 17):3073\u201384.","journal-title":"J Cell Sci"},{"issue":"1","key":"1956_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","volume":"57","author":"D Ito","year":"1998","unstructured":"Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57(1):1\u20139.","journal-title":"Brain Res Mol Brain Res"},{"issue":"6","key":"1956_CR79","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46(6):957\u201367.","journal-title":"Immunity."},{"key":"1956_CR80","first-page":"476380","volume":"2012","author":"F Emanuela","year":"2012","unstructured":"Emanuela F, Grazia M, Marco DR, Maria Paola L, Giorgio F, Marco B. Inflammation as a link between obesity and metabolic syndrome. J Nutri Metabol. 2012;2012:476380.","journal-title":"J Nutri Metabol"},{"issue":"4","key":"1956_CR81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MED.0b013e32833bf6dc","volume":"17","author":"CA Dinarello","year":"2010","unstructured":"Dinarello CA, Donath MY, Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabet Obesity. 2010;17(4):314\u201321.","journal-title":"Curr Opin Endocrinol Diabet Obesity"},{"issue":"10","key":"1956_CR82","first-page":"136","volume":"3","author":"W-Y Wang","year":"2015","unstructured":"Wang W-Y, Tan M-S, Yu J-T, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med. 2015;3(10):136.","journal-title":"Ann Transl Med"},{"issue":"3","key":"1956_CR83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1532-5415.1996.tb00912.x","volume":"44","author":"H White","year":"1996","unstructured":"White H, Pieper C, Schmader K, Fillenbaum G. Weight change in Alzheimer\u2019s disease. J Am Geriatr Soc. 1996;44(3):265\u201372.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1956_CR84","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/156720501303160217111434","volume":"13","author":"J Ma","year":"2016","unstructured":"Ma J, Zhang W, Wang HF, Wang ZX, Jiang T, Tan MS, et al. Peripheral blood adipokines and insulin levels in patients with Alzheimer\u2019s disease: a replication study and meta-analysis. Curr Alzheimer Res. 2016;13(3):223\u201333.","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"1956_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043193","volume":"7","author":"LR Freeman","year":"2012","unstructured":"Freeman LR, Zhang L, Dasuri K, Fernandez-Kim SO, Bruce-Keller AJ, Keller JN. Mutant amyloid precursor protein differentially alters adipose biology under obesogenic and non-obesogenic conditions. PLoS One. 2012;7(8):e43193.","journal-title":"PLoS One"},{"issue":"15","key":"1956_CR86","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1073\/pnas.1000645107","volume":"107","author":"S Takeda","year":"2010","unstructured":"Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A. 2010;107(15):7036\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1956_CR87","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","volume":"19","author":"SJ Greco","year":"2010","unstructured":"Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, Ashford JW, et al. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2010;19(4):1155\u201367.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1956_CR88","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/gt.2013.85","volume":"21","author":"R P\u00e9rez-Gonz\u00e1lez","year":"2014","unstructured":"P\u00e9rez-Gonz\u00e1lez R, Alvira-Botero MX, Robayo O, Antequera D, Garz\u00f3n M, Mart\u00edn-Moreno AM, et al. Leptin gene therapy attenuates neuronal damages evoked by amyloid-\u03b2 and rescues memory deficits in APP\/PS1 mice. Gene Ther. 2014;21(3):298\u2013308.","journal-title":"Gene Ther"},{"issue":"11","key":"1956_CR89","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.biopsych.2008.10.006","volume":"65","author":"K Narita","year":"2009","unstructured":"Narita K, Kosaka H, Okazawa H, Murata T, Wada Y. Relationship between plasma leptin level and brain structure in elderly: a voxel-based morphometric study. Biol Psychiatry. 2009;65(11):992\u20134.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"1956_CR90","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.neurobiolaging.2007.11.024","volume":"30","author":"KF Holden","year":"2009","unstructured":"Holden KF, Lindquist K, Tylavsky FA, Rosano C, Harris TB, Yaffe K. Serum leptin level and cognition in the elderly: findings from the health ABC study. Neurobiol Aging. 2009;30(9):1483\u20139.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1956_CR91","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s11064-017-2362-1","volume":"44","author":"G McGregor","year":"2019","unstructured":"McGregor G, Harvey J. Leptin regulation of synaptic function at hippocampal TA-CA1 and SC-CA1 synapses: implications for health and disease. Neurochem Res. 2019;44(3):650\u201360.","journal-title":"Neurochem Res"},{"issue":"6","key":"1956_CR92","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1440-1819.2010.02145.x","volume":"64","author":"MB Spitznagel","year":"2010","unstructured":"Spitznagel MB, Benitez A, Updegraff J, Potter V, Alexander T, Glickman E, et al. Serum ghrelin is inversely associated with cognitive function in a sample of non-demented elderly. Psychiatry Clin Neurosci. 2010;64(6):608\u201311.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"1956_CR93","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3233\/JAD-170721","volume":"61","author":"X Cao","year":"2018","unstructured":"Cao X, Zhu M, He Y, Chu W, Du Y, Du H. Increased serum acylated ghrelin levels in patients with mild cognitive impairment. J Alzheimers Dis. 2018;61(2):545\u201352.","journal-title":"J Alzheimers Dis"},{"key":"1956_CR94","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1038\/srep11452","volume":"5","author":"N Kunath","year":"2015","unstructured":"Kunath N, van Groen T, Allison DB, Kumar A, Dozier-Sharpe M, Kadish I. Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer\u2019s disease mouse model. Sci Rep. 2015;5:11452.","journal-title":"Sci Rep"},{"issue":"2","key":"1956_CR95","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3233\/JAD-190779","volume":"72","author":"J Tian","year":"2019","unstructured":"Tian J, Wang T, Wang Q, Guo L, Du H. MK0677, a ghrelin mimetic, improves neurogenesis but fails to prevent hippocampal lesions in a mouse model of Alzheimer\u2019s disease pathology. J Alzheimers Dis. 2019;72(2):467\u201378.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1956_CR96","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/ijms19061800","volume":"19","author":"YO Jeong","year":"2018","unstructured":"Jeong YO, Shin SJ, Park JY, Ku BK, Song JS, Kim JJ, et al. MK-0677, a ghrelin agonist, alleviates amyloid beta-related pathology in 5XFAD mice, an animal model of Alzheimer\u2019s disease. Int J Mol Sci. 2018;19(6):1800.","journal-title":"Int J Mol Sci"},{"key":"1956_CR97","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neubiorev.2015.08.021","volume":"67","author":"VA Moser","year":"2016","unstructured":"Moser VA, Pike CJ. Obesity and sex interact in the regulation of Alzheimer\u2019s disease. Neurosci Biobehav Rev. 2016;67:102\u201318.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"1956_CR98","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/01.CIR.64.3.477","volume":"64","author":"D Od","year":"1981","unstructured":"Od D, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M. Obesity and cardiac function. Circulation. 1981;64(3):477\u201382.","journal-title":"Circulation."},{"issue":"19","key":"1956_CR99","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/jama.2013.281901","volume":"310","author":"J Jin","year":"2013","unstructured":"Jin J, et al. Obesity and the Heart. JAMA. 2013;310(19):2113.","journal-title":"JAMA"},{"key":"1956_CR100","doi-asserted-by":"crossref","unstructured":"Salinero AE, Robison LS, Gannon OJ, Riccio DA, Mansour F, Abi Ghanem C, et al. Sex-specific effects of high fat diet on cognitive impairment in a mouse model of VCID. FASEB. 2020.","DOI":"10.1096\/fj.202000085R"},{"key":"1956_CR101","doi-asserted-by":"crossref","unstructured":"Robison LS, Albert NM, Camargo LA, Anderson BM, Salinero AE, Riccio DA, et al. High fat diet-induced obesity causes sex-specific deficits in adult hippocampal neurogenesis in mice. eneuro. 2019:ENEURO.0391-19.2019.","DOI":"10.1523\/ENEURO.0391-19.2019"},{"issue":"8","key":"1956_CR102","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","volume":"12","author":"HH Ruiz","year":"2016","unstructured":"Ruiz HH, Chi T, Shin AC, Lindtner C, Hsieh W, Ehrlich M, et al. Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels. Alzheimers Dement. 2016;12(8):851\u201361.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1956_CR103","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00125-010-1663-6","volume":"53","author":"K Kantartzis","year":"2010","unstructured":"Kantartzis K, Machann J, Schick F, Fritsche A, H\u00e4ring HU, Stefan N. The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia. 2010;53(5):882\u20139.","journal-title":"Diabetologia."},{"key":"1956_CR104","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ebiom.2015.12.008","volume":"3","author":"LA Johnson","year":"2015","unstructured":"Johnson LA, Zuloaga KL, Kugelman TL, Mader KS, Morr\u00e9 JT, Zuloaga DG, et al. Amelioration of metabolic syndrome-associated cognitive impairments in mice via a reduction in dietary fat content or infusion of non-diabetic plasma. EBioMedicine. 2015;3:26\u201342.","journal-title":"EBioMedicine."},{"issue":"3","key":"1956_CR105","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000153423","volume":"15","author":"LA Velloso","year":"2008","unstructured":"Velloso LA, Ara\u00fajo EP, de Souza CT. Diet-induced inflammation of the hypothalamus in obesity. Neuroimmunomodulation. 2008;15(3):189\u201393.","journal-title":"Neuroimmunomodulation."},{"issue":"1","key":"1956_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190205","volume":"13","author":"K Do","year":"2018","unstructured":"Do K, Laing BT, Landry T, Bunner W, Mersaud N, Matsubara T, et al. The effects of exercise on hypothalamic neurodegeneration of Alzheimer\u2019s disease mouse model. PLoS One. 2018;13(1):e0190205.","journal-title":"PLoS One"},{"issue":"1","key":"1956_CR107","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ijo.2016.183","volume":"41","author":"PS Dalvi","year":"2017","unstructured":"Dalvi PS, Chalmers JA, Luo V, Han DY, Wellhauser L, Liu Y, et al. International journal of obesity (2005). 2017;41(1):149\u201358.","journal-title":"International journal of obesity (2005)"},{"issue":"7","key":"1956_CR108","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1053\/j.gastro.2020.02.020","volume":"158","author":"N Gehrke","year":"2020","unstructured":"Gehrke N, Schattenberg JM. Metabolic inflammation-a role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease? Gastroenterology. 2020;158(7):1929\u201347.e6.","journal-title":"Gastroenterology"},{"issue":"4","key":"1956_CR109","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11011-011-9261-y","volume":"26","author":"DA Ghareeb","year":"2011","unstructured":"Ghareeb DA, Hafez HS, Hussien HM, Kabapy NF. Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. Metab Brain Dis. 2011;26(4):253\u201367.","journal-title":"Metab Brain Dis"},{"issue":"2","key":"1956_CR110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s13539-010-0015-1","volume":"1","author":"TP Braun","year":"2010","unstructured":"Braun TP, Marks DL. Pathophysiology and treatment of inflammatory anorexia in chronic disease. J Cachexia Sarcopenia Muscle. 2010;1(2):135\u201345.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1956_CR111","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/JME-16-0182","volume":"58","author":"P Argente-Ariz\u00f3n","year":"2017","unstructured":"Argente-Ariz\u00f3n P, Guerra-Cantera S, Garcia-Segura LM, Argente J, Chowen JA. Glial cells and energy balance. J Mol Endocrinol. 2017;58(1):R59\u2013r71.","journal-title":"J Mol Endocrinol"},{"issue":"33","key":"1956_CR112","doi-asserted-by":"publisher","first-page":"14875","DOI":"10.1073\/pnas.1004282107","volume":"107","author":"TL Horvath","year":"2010","unstructured":"Horvath TL, Sarman B, Garc\u00eda-C\u00e1ceres C, Enriori PJ, Sotonyi P, Shanabrough M, et al. Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc Natl Acad Sci U S A. 2010;107(33):14875\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1956_CR113","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnmol.2018.00002","volume":"11","author":"P Vercruysse","year":"2018","unstructured":"Vercruysse P, Vieau D, Blum D, Peters\u00e9n \u00c5, Dupuis L. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front Mol Neurosci. 2018;11:2.","journal-title":"Front Mol Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-020-01956-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T12:43:53Z","timestamp":1696769033000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-01956-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1956"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-01956-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.06.189928","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}